reference/32137412

http://rdf.ncbi.nlm.nih.gov/pubchem/reference/32137412

Outgoing Links

Predicate	Object
contentType	Clinical Trial\|Comparative Study\|Journal Article\|Multicenter Study\|Randomized Controlled Trial\|Research Support, Non-U.S. Gov't
endingPage	85
issn	1476-4180 1476-4172
issueIdentifier	2
pageRange	79-85
publicationName	Journal of cosmetic and laser therapy : official publication of the European Society for Laser Dermatology
startingPage	79
bibliographicCitation	Lowe NJ, Gifford M, Tanghetti E, Poulin YP, Goldman M, Tse Y, Yamauchi P, Rosenzweig H, Kang S. Tazarotene 0.1% cream versus tretinoin 0.05% emollient cream in the treatment of photodamaged facial skin: a multicenter, double‐blind, randomized, parallel‐group study. Journal of Cosmetic and Laser Therapy. 2004 Jun;6(2):79–85. doi: 10.1080/14764170410032406.
creator	http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_603c4c330ea6815ecfb03f0630fedbb0 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_ab316e04833c9f939c53b497300fd2f0 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_9d05ca27cfb423cb504413fc684b7429 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_0446722ee4e4b6b7935659c135bae003 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_b23a37f54f10387f89e4c95663a7e252 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_8347deb129c6b533ead1c45360c0a01e http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_6a5ed87b0bf50d043f0d2efe8305daea http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_4733b4d13ccf03baabca48b8bcd542b0 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_dcbc03c878b5c8e0a2e538b0f154a1db
date	200406
identifier	https://pubmed.ncbi.nlm.nih.gov/15203997 https://doi.org/10.1080/14764170410032406
isPartOf	https://portal.issn.org/resource/ISSN/1476-4180 https://portal.issn.org/resource/ISSN/1476-4172 http://rdf.ncbi.nlm.nih.gov/pubchem/journal/27072
language	English
source	https://pubmed.ncbi.nlm.nih.gov/ https://www.crossref.org/
title	Tazarotene 0.1% cream versus tretinoin 0.05% emollient cream in the treatment of photodamaged facial skin: a multicenter, double‐blind, randomized, parallel‐group study
discusses	http://id.nlm.nih.gov/mesh/M0006057 http://id.nlm.nih.gov/mesh/M0021879 http://id.nlm.nih.gov/mesh/M0014839 http://id.nlm.nih.gov/mesh/M0230113 http://id.nlm.nih.gov/mesh/M0007304
hasPrimarySubjectTerm	http://id.nlm.nih.gov/mesh/D014212Q000008 http://id.nlm.nih.gov/mesh/D009539Q000008 http://id.nlm.nih.gov/mesh/D015595Q000187 http://id.nlm.nih.gov/mesh/D003879Q000008
hasSubjectTerm	http://id.nlm.nih.gov/mesh/D004643 http://id.nlm.nih.gov/mesh/D006801 http://id.nlm.nih.gov/mesh/D000287 http://id.nlm.nih.gov/mesh/D005145 http://id.nlm.nih.gov/mesh/D016896 http://id.nlm.nih.gov/mesh/D004311 http://id.nlm.nih.gov/mesh/D008875 http://id.nlm.nih.gov/mesh/D005260 http://id.nlm.nih.gov/mesh/D008297 http://id.nlm.nih.gov/mesh/D017495Q000188
discussesAsDerivedByTextMining	http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID444795 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5381 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID10034

Incoming Links

Predicate	Subject
isDiscussedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128806208

Total number of triples: 51.